| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HARTFORD FINL SVCS GROUP INC | 900 | 34,000 | 0.00% | Call | |
| 2 | AURIS MED HLDG AG | 15,300 | 88,000 | 0.00% | ||
| 3 | CYTOKINETICS INC | 30,881 | 109,000 | 0.00% | ||
| 4 | UNIQURE NV | 12,050 | 111,000 | 0.00% | ||
| 5 | ACHAOGEN INC COM | 13,414 | 120,000 | 0.00% | ||
| 6 | CELLADON CORP | 14,300 | 150,000 | 0.00% | ||
| 7 | Agile Therapeutics, Inc. | 25,850 | 189,000 | 0.00% | ||
| 8 | GLYCOMIMETICS INC | 30,088 | 209,000 | 0.00% | ||
| 9 | MACROGENICS INC | 10,435 | 218,000 | 0.00% | ||
| 10 | XENCOR INC COM | 23,667 | 220,000 | 0.00% | ||
| 11 | GENOCEA BIOSCIENCES INC | 25,000 | 226,000 | 0.00% | ||
| 12 | CYTOKINETICS INC | 65,789 | 232,000 | 0.00% | Call | |
| 13 | FATE THERAPEUTICS INC | 51,482 | 263,000 | 0.01% | ||
| 14 | TETRALOGIC PHARMA CO | 79,196 | 329,000 | 0.01% | ||
| 15 | MARRONE BIO INNOVATIONS INC | 125,412 | 334,000 | 0.01% | ||
| 16 | ADAMAS PHARMACEUTICALS INC | 21,978 | 409,000 | 0.01% | ||
| 17 | LINCOLN EDL SVCS CORP | 154,280 | 434,000 | 0.01% | ||
| 18 | APPLIED GENETIC TECHNOL CORP | 25,827 | 481,000 | 0.01% | ||
| 19 | Vocera Communications Inc | 59,630 | 481,000 | 0.01% | ||
| 20 | QUINSTREET INC COM USD0.001 | 117,797 | 489,000 | 0.01% | ||
| 21 | AERIE PHARMACEUTICALS INC COM | 24,927 | 516,000 | 0.01% | ||
| 22 | MANCHESTER UTD PLC NEW ORD CL A | 31,656 | 522,000 | 0.01% | ||
| 23 | FCB Financial Holdings Inc | 38,216 | 534,000 | 0.01% | ||
| 24 | Gevo Inc | 1,567,064 | 537,000 | 0.01% | ||
| 25 | REVANCE THERAPEUTICS INC COM | 32,360 | 626,000 | 0.01% | ||
| 26 | AFFIMED N V COM | 100,000 | 630,000 | 0.01% | ||
| 27 | LOXO ONCOLOGY INC COM | 50,449 | 662,000 | 0.01% | ||
| 28 | ATRICURE INC | 45,625 | 672,000 | 0.01% | ||
| 29 | GSV CAP CORP | 67,254 | 673,000 | 0.01% | ||
| 30 | Gevo Inc | 2,000,000 | 685,000 | 0.01% | Call | |
| 31 | AQUINOX PHARMACEUTICALS INC | 105,646 | 704,000 | 0.01% | ||
| 32 | ALDER BIOPHARMACEUTICALS INC | 56,937 | 722,000 | 0.01% | ||
| 33 | CVR REFNG LP | 31,680 | 738,000 | 0.02% | ||
| 34 | TRUPANION INC | 88,020 | 748,000 | 0.02% | ||
| 35 | RLJ ENTMT INC | 200,000 | 774,000 | 0.02% | Call | |
| 36 | IMPRIVATA INC | 50,000 | 776,000 | 0.02% | ||
| 37 | ARGOS THERAPEUTICS INC | 79,430 | 799,000 | 0.02% | ||
| 38 | LOMBARD MEDICAL INC | 104,109 | 801,000 | 0.02% | ||
| 39 | OPOWER INC | 43,144 | 814,000 | 0.02% | ||
| 40 | INTRA-CELLULAR THERAPIES INC | 59,995 | 823,000 | 0.02% | ||
| 41 | IMMUNE DESIGN CORP | 46,833 | 827,000 | 0.02% | ||
| 42 | SUPERNUS PHARMACEUTICALS INC | 99,547 | 865,000 | 0.02% | ||
| 43 | DICERNA PHARMACEUTICALS INC | 68,406 | 871,000 | 0.02% | ||
| 44 | AUSPEX PHARMACEUTICALS INC | 34,856 | 895,000 | 0.02% | ||
| 45 | VITESSE SEMICONDUCTOR CORP | 250,000 | 900,000 | 0.02% | ||
| 46 | Innocoll | 136,422 | 900,000 | 0.02% | ||
| 47 | KYTHERA BIOPHARMACEUTICALS I | 28,342 | 928,000 | 0.02% | ||
| 48 | ZS PHARMA INC | 23,930 | 939,000 | 0.02% | ||
| 49 | TREVENA INC | 150,266 | 965,000 | 0.02% | ||
| 50 | ZHAOPIN LTD | 75,000 | 973,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-14-000207, filed 2014.11.14), New Holdings filing (0001164691-15-000179, filed 2015.11.19), New Holdings filing (0001164691-15-000140, filed 2015.08.17), New Holdings filing (0001164691-15-000101, filed 2015.05.21). and New Holdings filing (0001164691-15-000056, filed 2015.02.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
